Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Shareholder value

<< Previous

Bullboard Posts

Next >>

Comment by Marv1010on Nov 23, 2023 6:44am

99 Views

Post# 35749643

RE:Shareholder value

You think doing a 10:1 RS isn't a slap in the face of current shareholders? haha.

I agree that at this point M&A isn't the right look but neither is doing a RS when it would punish long term shareholders. I agree that a buyback would make lots of sense at this level but really, if mgmt are confident in the pharma angle, we could see billion dollar market caps in a blink which makes the shares O/S meaningless.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property